Treatment of Non-neurogenic Overactive Bladder with OnabotulinumtoxinA: Systematic Review and Meta-analysis of Prospective, Randomized, Placebo-controlled Clinical Trials. [PDF]
Rev Bras Ginecol Obstet, 2018 Arruda RM +5 more
europepmc +1 more source
The Ochoa urofacial syndrome: recognize the peculiar smile and avoid severe urological and renal complications. [PDF]
Einstein (Sao Paulo), 2015 Rondon AV +5 more
europepmc +1 more source
Epidemiology of cauda equina syndrome. What changed until 2015. [PDF]
Rev Bras Ortop, 2018 Dias ALN +5 more
europepmc +1 more source
Intradetrusor onabotulinumtoxinA injections are significantly more efficacious than oral oxybutynin for treatment of neurogenic detrusor overactivity: results of a randomized, controlled, 24-week trial. [PDF]
Einstein (Sao Paulo), 2018 Ferreira RS +3 more
europepmc +1 more source
Cross-cultural adaptation and validation of the neurogenic bladder symptom score questionnaire for Brazilian Portuguese. [PDF]
Int Braz J Urol, 2019 Cintra LKL +8 more
europepmc +1 more source
Interferon beta-1a treatment in HTLV-1-associated myelopathy/tropical spastic paraparesis: a case report. [PDF]
Rev Inst Med Trop Sao Paulo, 2014 Viana GM +5 more
europepmc +1 more source
Treating Numbers or Patients? Rethinking Supine Hypertension in Hospitalized Adults. [PDF]
Arq Bras CardiolTeixeira C.
europepmc +1 more source
Assessment of bladder volume by nurses using point-of-care ultrasound: a cross-sectional study. [PDF]
Rev Esc Enferm USPFuzaro T +5 more
europepmc +1 more source
Validation of a mobile application for adults with neurological lower urinary tract dysfunction. [PDF]
Rev Lat Am EnfermagemGomes DSLF +3 more
europepmc +1 more source
Self-care conditioning factors in women and men with urinary incontinence and Human T-Lymphotropic Virus Type 1. [PDF]
Rev Esc Enferm USPParanhos RFB +7 more
europepmc +1 more source